Rachel L. Mintz, Yeh‐Hsing Lao, Chun‐Wei Chi, Siyu He, Mingqiang Li, Chai Hoon Quek, . . . Kam W. Leong. (2020). CRISPR/Cas9‐mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1‐mutated breast cancer cells. Wiley.
Chicago Style (17th ed.) CitationRachel L. Mintz, et al. CRISPR/Cas9‐mediated Mutagenesis to Validate the Synergy Between PARP1 Inhibition and Chemotherapy in BRCA1‐mutated Breast Cancer Cells. Wiley, 2020.
MLA (9th ed.) CitationRachel L. Mintz, et al. CRISPR/Cas9‐mediated Mutagenesis to Validate the Synergy Between PARP1 Inhibition and Chemotherapy in BRCA1‐mutated Breast Cancer Cells. Wiley, 2020.
Warning: These citations may not always be 100% accurate.